Table 1

Demographics of patient groups

High myopiaMild and moderate myopiaEmmetropia and hyperopia
All macular holes
Axial length≥26.0 mm23.0–25.99 mm<23.0 mm
No of patients201754
    Men5 (25.0%)4 (23.5%)16 (32.7%)
    Women15 (75.0%)13 (76.5%)33 (67.3%)
Age (years)52.1 (10.3) (23 to 70)64.5 (8.5) (52 to 82)69.8 (5.7) (57 to 82)
No of eyes201856
    RE8 (40.0%)10 (55.6%)33 (59.6%)
    LE12 (60.0%)8 (44.4%)23 (41.4%)
Duration since the onset (weeks)7.6 (6.9) (1 to 24)8.0 (5.2) (2 to 24)9.4 (5.2) (1 to 24)
Refractive error (dioptres)−9.28 (2.31) (−17.0 to −7.0)−3.40 (1.17) (−8.0 to –2.0)+0.27 (1.23) (−3.5 to +6.0)
Axial length (mm)27.04 (0.93) (26.22 to 30.15)23.78 (0.78) (22.82 to 25.43)21.70 (0.71) (18.52 to 23.23)
Best corrected visual acuity0.164 (20/122.0) (0.05 to 0.4)0.180 (20/111.1) (0.03 to 0.4)0.148 (20/135.1) (0.05 to 0.4)
LogMAR0.786 (0.248)0.744 (0.271)0.828 (0.241)
Stage III macular holes
Axial length≥26.0 mm23.0–25.99 mm<23.0 mm
No of patients191541
    Men5 (25.0%)3 (20.0%)14 (34.2%)
    Women14 (75.0%)12 (80.0%)27 (65.8%)
Age (years)52.6 (10.3) (23 to 70)64.5 (8.5) (52 to 82)69.1 (6.4) (57 to 82)
No of eyes191641
    RE8 (42.1%)9 (56.3%)24 (59.0%)
    LE11 (57.9%)7 (43.7%)18 (41.0%)
Duration since the onset (months)6.9 (6.5) (1 to 24)8.0 (5.2) (2 to 24)7.6 (5.4) (1 to 24)
Refractive error (dioptres)−9.34 (2.36) (−17.0 to −7.0)−3.40 (1.17) (−8.0 to −2.0)+0.27 (1.24) (−3.5 to +6.0)
Axial length (mm)27.07 (0.94) (26.22 to 30.15)23.78 (0.78) (22.82 to 25.43)21.60 (0.70) (18.52 to 23.23)
Best corrected visual acuity0.172 (20/116.3) (0.05 to 0.4)0.200 (20/100.0) (0.03 to 0.4)0.158 (20/124.2) (0.03 to 0.4)
LogMAR0.764 (0.232)0.699 (0.271)0.795 (0.258)